Apollo Medical Hlgs Q2 EPS $0.28, Inline, Sales $348.21M Beat $341.10M Estimate
Portfolio Pulse from Benzinga Newsdesk
Apollo Medical Hlgs (NASDAQ:AMEH) reported Q2 earnings of $0.28 per share, in line with analyst consensus. This is a 12% increase YoY. The company also reported quarterly sales of $348.21M, beating the analyst consensus of $341.10M by 2.08%, a 29.11% increase YoY.
August 07, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apollo Medical Hlgs reported Q2 earnings in line with estimates and sales beating estimates, indicating a positive financial performance.
Apollo Medical Hlgs reported Q2 earnings that met analyst expectations and sales that exceeded expectations. This indicates a strong financial performance, which is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100